Edoxaban Impurity 105 | CAS 2408469-02-1 - Request Quote
Edoxaban Impurity 105
| SZ CAT No: | SZ-E041125 |
| CAS No | 2408469-02-1 |
| Mol.F. | C9H9Cl3N2OS |
| Mol.Wt. | 299.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Edoxaban Impurity 105 is chemically 2,2,2-Trichloro-1-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)ethan-1-one. Edoxaban Impurity 105 is supplied with detailed characterization data compliant with regulatory guideline. Edoxaban Impurity 105 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Edoxaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2408469-02-1
Purchase 2408469-02-1
Order 2408469-02-1
Enquire 2408469-02-1
price of 2408469-02-1
2408469-02-1 Supplier
2408469-02-1 Manufacturer
2408469-02-1 Exporter
buy high quality Edoxaban Impurity 105
Purchase Edoxaban Impurity 105
Edoxaban Impurity 105 suppliers
Edoxaban Impurity 105 manufacturers
Edoxaban Impurity 105 price
Order Edoxaban Impurity 105
Enquire Edoxaban Impurity 105
Edoxaban Impurity 105 cost
Edoxaban Impurity 105 Supplier
Edoxaban Impurity 105 Distributor
Edoxaban Impurity 105 for Method Validation
Edoxaban Reference Standard
Edoxaban Impurity 105 for ANDA Filing
Edoxaban Impurity 105 for Forced Degradation Studies
Edoxaban Impurity 105 Identification Standards
Edoxaban Impurity 105 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.